A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections

Patients undergoing emergency gastrointestinal surgery for intra-abdominal infection are at high risk for invasive candidiasis. This exploratory clinical trial could not provide evidence that a preemptive antifungal treatment strategy was effective in this patient group.

• Publication year

  2015

• Venue

  Clinical Infectious Diseases

• Publication date

  2015-08-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cid/civ707PMID 26270686PMCID 4643488
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.

  2015cited by this paper
• MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

  2014cited by this paper
• β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

  2013cited by this paper
• Intra-abdominal candidiasis: the guidelines—forgotten non-candidemic invasive candidiasis

  2013cited by this paper
• A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts

  2013cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

  2012cited by this paper
• β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

  2012cited by this paper
• Diagnosis of invasive candidiasis in the ICU

  2011cited by this paper
• Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index

  2011cited by this paper
• Prospective Survey of (1→3)-β-d-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting

  2010cited by this paper
• Early antifungal intervention strategies in ICU patients

  2010cited by this paper
• Empirical Fluconazole versus Placebo for Intensive Care Unit Patients: A Randomized Trial

  2009cited by this paper
• International study of the prevalence and outcomes of infection in intensive care units.

  2009cited by this paper
• International study of the prevalence and outcomes of infection in intensive care units

  2009cited by this paper
• Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study

  2009cited by this paper
• Management of candidiasis in the intensive care unit.

  2008cited by this paper
• Empirical Fluconazole versus Placebo for Intensive Care Unit Patients

  2008cited by this paper
• Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

  2007cited by this paper
• Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).

  2007cited by this paper
• Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

  2007cited by this paper
• A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*

  2006cited by this paper
• Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

  2006cited by this paper
• Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials.

  2005cited by this paper
• Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

  2005cited by this paper
• Clinical trials of antifungal prophylaxis among patients undergoing surgery.

  2004cited by this paper
• Epidemiology of Candida species infections in critically ill non-immunosuppressed patients.

  2003cited by this paper
• Management of candidiasis Management of Candida species infections in critically ill patients

  2003cited by this paper
• Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study.

  2003cited by this paper
• Management of Candida species infections in critically ill patients.

  2003cited by this paper
• Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination

  2002cited by this paper
• Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients

  2001cited by this paper
• Fluconazole Prophylaxis of Severe Candida Infection in Trauma and Postsurgical Patients: A Prospective, Double‐Blind, Randomized, Placebo‐Controlled Trial

  2000cited by this paper
• Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

  1999cited by this paper
• Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients.

  1994cited by this paper
• Candida Colonization and Subsequent Infections in Critically III Surgical Patients

  1994cited by this paper
• Risk factors for hospital-acquired candidemia. A matched case-control study.

  1989cited by this paper
• Ketoconazole prevents Candida sepsis in critically ill surgical patients.

  1987cited by this paper

• Antifungal treatment strategies in intensive care unit patients

  2026cites this paper
• Knowledge, Attitudes and Practices of Physicians Regarding Antifungal Therapy in Tertiary Care Patients: A Cross-Sectional Survey in Greece.

  2026cites this paper
• The Role of Empiric Antifungal Therapy in Patients With Perforated Peptic Ulcer: An Updated Systematic Review and Meta-Analysis

  2025cites this paper
• Candida auris in intensive care unit: A growing clinical concern

  2025cites this paper
• Invasive candidiasis in critically ill patients: Fundamental concepts and future directions.

  2025cites this paper
• Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?

  2025cites this paper
• Infections in Heart and Lung Transplant Recipients.

  2024cites this paper
• Rapid detection of pathogenic fungi from coastal population with respiratory infections using microfluidic chip technology

  2024cites this paper
• Empirical Therapy for Invasive Candidiasis in Critically Ill Patients

  2024influential citation
• Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients: An Official American Thoracic Society Clinical Practice Guideline

  2024influential citation
• Empirical antifungal therapy for health care-associated intra-abdominal infection: a retrospective, multicentre and comparative study

  2024cites this paper
• Risk Factors for Invasive Candidiasis in Critically Ill Patients Who Underwent Emergency Gastrointestinal Surgery for Complicated Intra-Abdominal Infection

  2024influential citation
• Prophylaxis of Invasive Fungal Infection in Neonates: A Narrative Review for Practical Purposes

  2023cites this paper
• Use of 1,3-Beta-D-Glucan concentration in peritoneal fluid for the diagnosis of intra-abdominal Candidiasis in Critically-ill patients.

  2023cites this paper
• (1 → 3)-β-d-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial

  2022cites this paper
• Korean Guidelines for Use of Antibiotics for Intra-abdominal Infections in Adults

  2022cites this paper
• Effect of empirical antifungal treatment on mortality in non-neutropenic critically ill patients: a propensity-matched retrospective cohort study

  2022cites this paper
• Comparative efficacy and safety of systemic antifungal agents for candidemia: A systematic review with network meta-analysis and multicriteria acceptability analyses.

  2022cites this paper
• Is ß-d-glucan Relevant for the Diagnosis and Follow-Up of Intensive Care Patients with Yeast-Complicated Intra-Abdominal Infection?

  2022cites this paper
• Epidemiology of candidemia in lung transplant recipients and risk factors for candidemia in the early posttransplant period in the absence of universal antifungal prophylaxis

  2022cites this paper
• Evaluation of a stewardship program of antifungal use at a Brazilian tertiary care hospital

  2022cites this paper
• Peritoniti secondarie negli adulti

  2022cites this paper
• Peritonitis secundarias del adulto

  2022cites this paper
• Candida isolation from peritoneal fluid: Its role in the outcome of patients with perforation peritonitis

  2021cites this paper
• Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study

  2021cites this paper
• Longitudinal Evaluation of Plasma Cytokine Levels in Patients with Invasive Candidiasis

  2021cites this paper
• Use and outcome of empiric echinocandins in critically ill patients

  2021cites this paper
• Echinocandins

  2021cites this paper
• Péritonites secondaires de l’adulte

  2021cites this paper
• Pilzinfektionen in der AVC

  2021cites this paper
• Invasive Candidiasis in Surgical Patients

  2021cites this paper
• Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients

  2020cites this paper
• Invasive candidiasis in critical care: challenges and future directions

  2020cites this paper
• T2Candida magnetic resonance in patients with invasive candidiasis: Strengths and limitations.

  2020cites this paper
• Issues and Concerns in the Management of Systemic Candidiasis

  2020cites this paper
• The presence of (1-3)-β-D-Glucan as prognostic marker in patients post major abdominal surgery.

  2020cites this paper
• What´s new in intraabdominal candidiasis in critically ill patients, a review

  2019cites this paper
• Association of Immune Cell Subtypes and Phenotype with Subsequent Invasive Candidiasis in Patients with Abdominal Sepsis.

  2019cites this paper
• Infections in Heart and Lung Transplant Recipients.

  2019cites this paper
• Gut Leakage of Fungal-Derived Inflammatory Mediators: Part of a Gut-Liver-Kidney Axis in Bacterial Sepsis

  2019cites this paper
• ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients

  2019cites this paper
• Imaging Imaging and intensive care medicine : an evolving partnership , A . McLean Whole-body ultrasound in the intensive care unit : bedside ultrasound of the whole body

  2019cites this paper
• Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology

  2019cites this paper
• Diagnosis of Systemic Fungal Diseases

  2019cites this paper
• Antifungal agents for invasive candidiasis in non-neutropenic critically-ill adults: what do the guidelines recommend?

  2019cites this paper
• Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

  2019cites this paper
• Empirical anidulafungin therapy increases the treatment efficacy in invasive candidiasis: ERA study results (EraxisR in the Russian Federation)

  2019cites this paper
• Risk factors of invasive candidiasis in critical cancer patients after various gastrointestinal surgeries

  2019cites this paper
• Management of patients with septic shock due to Candida infection

  2018cites this paper
• The Role of Candida in Abdominal Sepsis

  2018cites this paper
• (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial

  2018cites this paper
• Candida albicans - Biology, molecular characterization, pathogenicity, and advances in diagnosis and control - An update.

  2018cites this paper
• Use of T2MR in invasive candidiasis with and without candidemia.

  2018cites this paper
• Untargeted antifungal therapy in adult patients with complicated intra‐abdominal infection: a systematic review

  2018influential citation
• Diagnosing Invasive Candidiasis

  2018cites this paper
• Invasive candidiasis

  2018cites this paper
• What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead

  2018cites this paper
• What every intensivist should know about the management of peritonitis in the intensive care unit

  2018cites this paper
• Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences

  2018cites this paper
• Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan.

  2018cites this paper
• PCR-Based Methods for the Diagnosis of Invasive Candidiasis: Are They Ready for Use in the Clinic?

  2018cites this paper
• The EMPIRICUS trial-the final nail in the coffin of empirical antifungal therapy in the intensive care unit?

  2017cites this paper
• Lessons from uncertainty on antifungal treatment in ICU.

  2017cites this paper
• New developments and directions in the clinical application of the echinocandins

  2017cites this paper
• Critically ill patients at risk of invasive candidiasis: The "dilemma" of the best antifungal treatment strategy.

  2017cites this paper
• Antifungal Prevention of Systemic Candidiasis in Immunocompetent ICU Adults: Systematic Review and Meta-Analysis of Clinical Trials

  2017cites this paper
• Fungal Versus Bacterial Infection in Severe Acute Pancreatitis

  2017cites this paper
• Intra-Abdominal Candidiasis

  2017cites this paper
• Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis

  2017cites this paper
• Untargeted Antifungal Treatment Strategies for Invasive Candidiasis in Non-neutropenic Critically Ill Patients: Current Evidence and Insights

  2017cites this paper
• The impact of real life treatment strategies for Candida peritonitis—A retrospective analysis

  2017cites this paper
• Should we Administer Antifungal Drugs Before the Diagnosis of Invasive Fungal Infection in Non-Neutropenic Critically Ill Patients?

  2017cites this paper
• Uncertainty about the evidence on untargeted antifungal treatment.

  2017cites this paper
• Initial therapeutic strategy of invasive candidiasis for intensive care unit patients: a retrospective analysis from the China-SCAN study

  2017cites this paper
• What Is the Most Recent Evidence on the Prevention and Early Treatment of Invasive Fungal Infections in Nonneutropenic Critically Ill Patients

  2017cites this paper
• Fungal and Viral Infections

  2017cites this paper
• Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer.

  2017cites this paper
• Abdominal Sepsis

  2016cites this paper
• Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA)

  2016cites this paper
• The paradox of the evidence about invasive fungal infection prevention

  2016cites this paper
• Candidemia and invasive candidiasis in adults: A narrative review.

  2016cites this paper
• The Molecular Basis of Procalcitonin Synthesis in Different Infectious and Non-Infectious Acute Conditions

  2016cites this paper
• Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy

  2016cites this paper
• Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.

  2016cites this paper
• Update in Critical Care 2015.

  2016cites this paper
• Contemporary Strategies in the Prevention and Management of Fungal Infections.

  2016cites this paper
• Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies

  2016cites this paper
• Quoi de neuf dans la prise en charge des péritonites postopératoires

  2016cites this paper
• Recommendations for intra-abdominal infections consensus report.

  2016cites this paper
• Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment

  2016cites this paper
• Antifungal Stewardship: an Emerging Practice in Antimicrobial Stewardship

  2016cites this paper
• World Journal of Gastrointestinal Surgery

  year unknowninfluential citation